N. G. Seidah and M. Chretien, Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides, Brain Res, vol.848, pp.45-62, 1999.

A. M. Khatib, G. Siegfried, M. Chretien, P. Metrakos, and N. G. Seidah, Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy, Am J Pathol, vol.160, pp.1921-1956, 2002.

Y. Bontemps, N. Scamuffa, F. Calvo, and A. M. Khatib, Potential opportunity in the development of new therapeutic agents based on endogenous and exogenous inhibitors of the proprotein convertases, Med Res Rev, vol.27, pp.631-679, 2007.

A. Basak, Inhibitors of proprotein convertases, J Mol Med, vol.83, pp.844-55, 2005.

G. Siegfried, A. M. Khatib, S. Benjannet, M. Chretien, and N. G. Seidah, The proteolytic processing of pro-plateletderived growth factor-A at RRKR(86) by members of the proprotein convertase family is functionally correlated to platelet-derived growth factor-A-induced functions and tumorigenicity, Cancer Res, vol.63, pp.1458-63, 2003.

G. Siegfried, A. Basak, and W. Prichett-pejic, Regulation of the stepwise proteolytic cleavage and secretion of PDGF-B by the proprotein convertases, Oncogene, vol.24, pp.6925-6960, 2005.

G. Siegfried, A. Basak, and J. A. Cromlish, The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis, J Clin Invest, vol.111, pp.1723-1755, 2003.

A. M. Khatib, G. Siegfried, A. Prat, J. Luis, M. Chretien et al., Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells: importance of insulin-like growth factor-1 (IGF-1) receptor processing in IGF-1-mediated functions, J Biol Chem, vol.276, pp.30686-93, 2001.

F. Jean, K. Stella, and L. Thomas, a1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent, Proc Natl Acad Sci U S A, vol.95, pp.7293-7301, 1998.

M. Cheng, P. H. Watson, J. A. Paterson, N. Seidah, M. Chretien et al., Pro-protein convertase gene expression in human breast cancer, Int J Cancer, vol.71, pp.966-71, 1997.

M. J. Duffy, T. M. Maguire, A. Hill, E. Mcdermott, O. Higgins et al., Metalloproteinases: role in breast carcinogenesis, invasion and metastasis, Breast Cancer Res, vol.2, pp.252-259, 2000.

M. Zhong, J. S. Munzer, and A. Basak, The prosegments of furin and PC7 as potent inhibitors of proprotein convertases. In vitro and ex vivo assessment of their efficacy and selectivity, J Biol Chem, vol.274, pp.33913-33933, 1999.

N. Nour, A. Basak, M. Chretien, and N. G. Seidah, Structurefunction analysis of the prosegment of the proprotein convertase PC5A, J Biol Chem, vol.278, pp.2886-95, 2003.

D. E. Bassi, H. Mahloogi, L. Al-saleem, L. De-cicco, R. Ridge et al., Elevated furin expression in aggressive human head and neck tumors and tumor cell lines, Mol Carcinog, vol.31, pp.224-256, 2001.

Y. Fu, E. J. Campbell, T. G. Shepherd, and M. W. Nachtigal, Epigenetic regulation of proprotein convertase PACE4 gene expression in human ovarian cancer cells, Mol Cancer Res, vol.1, pp.569-76, 2003.

D. E. Bassi, R. Lopez-de-cicco, H. Mahloogi, S. Zucker, G. Thomas et al., Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells, Proc Natl Acad Sci U S A, vol.98, pp.10326-10357, 2001.

M. Nejjari, V. Berthet, and V. Rigot, Inhibition of proprotein convertases enhances cell migration and metastases development of human colon carcinoma cells in a rat model, Am J Pathol, vol.164, pp.1925-1958, 2004.

R. Lopez-de-cicco, D. E. Bassi, S. Zucker, N. G. Seidah, and A. J. Klein-szanto, Human carcinoma cell growth and invasiveness is impaired by the propeptide of the ubiquitous proprotein convertase furin, Cancer Res, vol.65, pp.4162-71, 2005.

D. E. Bassi, H. Mahloogi, R. Lopez-de-cicco, and A. Klein-szanto, Increased furin activity enhances the malignant phenotype of human head and neck cancer cells, Am J Pathol, vol.162, pp.439-486, 2003.

H. Mahloogi, D. E. Bassi, and A. J. Klein-szanto, Malignant conversion of non-tumorigenic murine skin keratinocytes overexpressing PACE4, Carcinogenesis, vol.23, pp.565-72, 2002.